These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3257935)

  • 1. Faecal alpha-1-antitrypsin in chronic inflammatory bowel disease.
    Thomas DW
    Gut; 1988 Feb; 29(2):262-3. PubMed ID: 3257935
    [No Abstract]   [Full Text] [Related]  

  • 2. Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases.
    Fischbach W; Becker W; Mössner J; Koch W; Reiners C
    Gut; 1987 Apr; 28(4):386-93. PubMed ID: 3495470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease.
    Miura S; Yoshioka M; Tanaka S; Serizawa H; Tashiro H; Asakura H; Tsuchiya M
    J Gastroenterol Hepatol; 1991; 6(1):49-52. PubMed ID: 1909193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
    Fischbach W; Deubel M; Boege F; Mössner J
    Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of ulcerative colitis and Crohn's disease activity by measurement of alpha-1-antitrypsin intestinal clearance (author's transl)].
    Florent C; L'Hirondel C; Desmazures C; Giraudeaux V; Bernier JJ
    Gastroenterol Clin Biol; 1981 Feb; 5(2):193-7. PubMed ID: 6970700
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin.
    Bernier JJ; Florent C; Desmazures C; Aymes C; L'Hirondel C
    Lancet; 1978 Oct; 2(8093):763-4. PubMed ID: 80688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of intestinal clearance of alpha-1-antitrypsin in the diagnosis of protein-losing syndromes].
    Sategna-Guidetti C; Rutigliano A
    Recenti Prog Med; 1983 May; 74(5):543-52. PubMed ID: 6604301
    [No Abstract]   [Full Text] [Related]  

  • 8. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
    Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal alpha 1-antitrypsin clearance in patients with inflammatory bowel disease.
    Grill BB; Hillemeier AC; Gryboski JD
    J Pediatr Gastroenterol Nutr; 1984; 3(1):56-61. PubMed ID: 6607330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteric protein loss measured by fecal alpha 1-antitrypsin clearance in the assessment of Crohn's disease activity: a study of children and adolescents.
    Griffiths AM; Drobnies A; Soldin SJ; Hamilton JR
    J Pediatr Gastroenterol Nutr; 1986; 5(6):907-11. PubMed ID: 3491890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the composition of faecal fluid in Crohn's disease and ulcerative colitis.
    Schilli R; Breuer RI; Klein F; Dunn K; Gnaedinger A; Bernstein J; Paige M; Kaufman M
    Gut; 1982 Apr; 23(4):326-32. PubMed ID: 7076010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal proteolysis of albumin and IgG in Crohn's disease and ulcerative colitis.
    Soltoft J; Jarnum S
    Digestion; 1969; 2(5):282-8. PubMed ID: 5365260
    [No Abstract]   [Full Text] [Related]  

  • 14. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of intestinal inflammatory activity in Crohn disease using alpha 1-antitrypsin].
    Karbach U; Singe CC; Ewe K
    Dtsch Med Wochenschr; 1985 May; 110(19):778. PubMed ID: 3873330
    [No Abstract]   [Full Text] [Related]  

  • 16. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fecal inflammatory markers in Crohn disease].
    Singe CC
    Z Gastroenterol Verh; 1989 Jul; 24():35-7. PubMed ID: 2474978
    [No Abstract]   [Full Text] [Related]  

  • 18. [Appraisal of activity in Crohn's disease. Value of inflammatory tests, deconjugation tests and the absorption of bile salts and alpha l-antitrypsin clearance].
    Gillard C; Deflandre J; Brassinne A
    Acta Gastroenterol Belg; 1984; 47(3):309-16. PubMed ID: 6333769
    [No Abstract]   [Full Text] [Related]  

  • 19. Simplified determination of intestinal protein excretion based on alpha 1-antitrypsin clearance.
    Karbach U; Singe CC; Ewe K
    Z Gastroenterol; 1988 Mar; 26(3):169-73. PubMed ID: 3261475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha 1-antitrypsin and the percentage of fecal excretion of 111In-oxin-labeled leukocytes in Crohn disease].
    Fischbach W; Becker W
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1233. PubMed ID: 3874762
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.